Bristol-Myers names Bancroft as interim CFO, in lieu of Huet's departure
Pharmaceutical company Bristol-Myers Squibb has selected Charles Bancroft as its acting CFO, as its current executive vice president and CFO, Jean-Marc Huet, prepares to leave his post at the end of this year.

Effective Jan. 1, 2010, Bancroft, who previously served as vice president of the company, will report to BMS' President and COO Lamberto Andreotti.

According to the New York City-based company, Bancroft joined BMS in 1984 and has held several positions dealing with the organization's finances. 

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup